This inventor holds 2 USPTO granted patents. Top assignee: Elan Pharmaceuticals, Inc.. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: Susanna M S Chrysler: Innovator in Protease Research
Introduction
Susanna M S Chrysler is a notable inventor based in San Bruno, CA (US). She has made significant contributions to the field of protease research, particularly in the development of methods and compositions for inhibiting β-secretase. With a total of 2 patents, her work has implications for understanding and treating conditions related to β-amyloid precursor protein (APP).
Latest Patents
Chrysler's latest patents focus on innovative methods and compositions that involve a novel protease capable of cleaving β-amyloid precursor protein (APP). The first patent describes reaction systems that utilize β-secretase to monitor the cleavage of APP and identify potential inhibitors. The second patent similarly outlines the use of β-secretase in screening assays, emphasizing the importance of antibodies raised against peptides of β-secretase. These patents highlight her commitment to advancing pharmaceutical compositions and methods that can lead to significant medical breakthroughs.
Career Highlights
Susanna M S Chrysler is currently associated with Elan Pharmaceuticals, Inc., where she continues her research and development efforts. Her work has been instrumental in the field of biochemistry, particularly in understanding the mechanisms of β-secretase and its role in various diseases.
Collaborations
Chrysler has collaborated with notable colleagues such as Sukanto Sinha and Pamela S Keim. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the pharmaceutical industry.
Conclusion
Susanna M S Chrysler's contributions to protease research and her innovative patents underscore her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile